Lantheus Holdings to Present at the CJS Securities 18th Annual “New Ideas” Summer Conference
June 21 2018 - 4:05PM
Business Wire
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the
parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global
leader in the development, manufacture and commercialization of
innovative diagnostic imaging agents and products, today announced
that Mary Anne Heino, President and Chief Executive Officer, and
Jack Crowley, Chief Financial Officer, will present at the CJS
Securities 18th Annual “New Ideas” Summer Conference on Tuesday,
July 10, 2018, in White Plains, NY.
A copy of the presentation will be available on the Investors
section of the Company’s website at www.lantheus.com.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging,
Inc.Lantheus Holdings, Inc. is the parent company of LMI, a
global leader in the development, manufacture and commercialization
of innovative diagnostic imaging agents and products. LMI provides
a broad portfolio of products, including the echocardiography
contrast agent DEFINITY® Vial for (Perflutren Lipid Microsphere)
Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a
technetium-based generator that provides the essential medical
isotope used in nuclear medicine procedures; and Xenon (Xenon Xe
133 Gas), an inhaled radiopharmaceutical imaging agent used to
evaluate pulmonary function and for imaging the lungs. The Company
is headquartered in North Billerica, Massachusetts with offices in
Puerto Rico and Canada. For more information, visit
www.lantheus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180621005984/en/
Lantheus Holdings, Inc.Meara Murphy, 978-671-8508Director,
Investor Relations & Corporate Communications
Lantheus (NASDAQ:LNTH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lantheus (NASDAQ:LNTH)
Historical Stock Chart
From Apr 2023 to Apr 2024